Clinical Trials Logo

Clinical Trial Summary

The effect of beta-glucan or fructo-oligosaccharide or their combination in bars on satiety and food intake was tested by supplying these bars on two consecutive days.


Clinical Trial Description

Background: Increasing gastro-intestinal viscosity or colonic fermentation is suggested to help improve appetite control and reduce food intake. Beta-glucan (BG) and fructo-oligosaccharide (FOS) are food ingredients proposed to act this way, but results so far remain inconclusive.

Objective: To test the effect of FOS, BG, or their combination in bars on appetite ratings and food intake during 2 consecutive days.

Design: In a 4-way balanced order cross-over double-blind design, 21 healthy volunteers (mean BMI 25.9 kg/m2) received a meal replacement bar at 09.00h and an ad libitum lunch at 13.00h on 2 consecutive days. On day 1 only, subjects consumed a second (identical) bar at 17.00h and a fixed snack at 19.00h. The control bar contained 0.3g BG (control, from 6.8 g oats), vs equi-caloric bar formulations containing an additional: 1) 0.9 g BG (from 8.0g barley), 2) 8g FOS, or 3) 0.9 g BG + 8g FOS. Appetite scores and subsequent ad libitum test meal intakes were measured. Bar viscosities were determined under simulated gastric conditions. Results were analyzed using ANCOVA.

Results: Addition of BG, FOS or their combination did not affect appetite ratings or food intake, although addition of BG to the bar doubled apparent gastric viscosity (841 vs 351 mPa.s).

Conclusions: BG, FOS or their combination in bars at these levels do not improve appetite control when consumed on 2 consecutive days. Efficacy might be increased by a longer exposure period, increasing the BG content, or a form of BG that generates even higher gastric viscosity. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)


Related Conditions & MeSH terms


NCT number NCT00776256
Study type Interventional
Source Unilever R&D
Contact
Status Completed
Phase N/A
Start date February 2007
Completion date April 2007

See also
  Status Clinical Trial Phase
Completed NCT01240018 - ProSat - Long Term Effect of Probiotics on Satiety N/A
Recruiting NCT05587127 - Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia N/A
Active, not recruiting NCT02310360 - Striatal and Extra-striatal Dopamine Release in Response to Food in Healthy Humans N/A
Completed NCT02774486 - Efficacy and Safety of IQP-AK-102 in Reducing Appetite N/A
Completed NCT03322514 - Colonic Propionate, Appetite, and Weight Loss N/A
Completed NCT01965210 - The Effect of Dietary Fibre and Plant Protein on Appetite and Metabolic Function N/A
Completed NCT02487342 - Metabolic, Endocrine and Appetite-related Responses in Healthy, Adolescent Males After Acute and Daily Milk Consumption N/A
Completed NCT00912197 - Effect of Oligofructose on Appetite in Overweight Subjects N/A
Completed NCT03956732 - Effects of Milk Protein and Vitamin D on Children's Growth and Health N/A
Completed NCT03143868 - Role of Acute Exercise Modality on Appetite Regulation and Energy Intake N/A
Completed NCT04788069 - Effect of Sourdough Breads Consumption on Postprandial Responses, Satiety and Food Intake at Subsequent Meal N/A
Completed NCT01644539 - Brain Activity and Hormonal Changes During Food Administration N/A
Withdrawn NCT01152333 - The Role of GLP-1 in Satiety Perception in Humans N/A
Completed NCT03025997 - Lipid Encapsulation for Ileal Brake Activation N/A
Completed NCT01877460 - Sodium Alginate in Chocolate Milk, Satiety and Glycemic Control N/A
Completed NCT00826761 - ProSat - Effect of Probiotics on Satiety N/A
Completed NCT04345029 - Effectiveness of a Natural Ingredient on Appetite Regulation N/A
Completed NCT01259895 - Effects of Time of Sleep Restriction in Obesity N/A
Recruiting NCT05610124 - Postprandial Glycemia and Satiety of Meals With Potatoes, With and Without Protein N/A
Active, not recruiting NCT02310347 - Influence of a Medicinal Cannabinoid Agonist on Responses to Food Images and Food Intake N/A